Nephros, Inc. (NASDAQ:NEPH) Stock Holdings Decreased by Bard Associates Inc.

Bard Associates Inc. lowered its stake in Nephros, Inc. (NASDAQ:NEPH) by 9.9% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 155,271 shares of the company’s stock after selling 17,100 shares during the period. Bard Associates Inc. owned 1.47% of Nephros worth $228,000 as of its most recent SEC filing.

Nephros Stock Performance

NEPH opened at $1.41 on Tuesday. The company has a 50-day moving average of $1.55 and a 200-day moving average of $1.60. The company has a market capitalization of $14.87 million, a P/E ratio of -15.67 and a beta of 1.19. Nephros, Inc. has a 1-year low of $1.36 and a 1-year high of $3.19.

Analysts Set New Price Targets

Separately, Benchmark reissued a “speculative buy” rating and issued a $5.00 target price on shares of Nephros in a research report on Tuesday, November 12th.

About Nephros

Nephros, Inc, a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities.